Cart
sales@molnova.com
Xylocaine
CAS No. 137-58-6
Xylocaine ( NSC 40030 )
Catalog No. M11555 CAS No. 137-58-6
Lidocaine, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo, possibly due to an attenuation of pro-inflammatory cytokines.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 41 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXylocaine
-
NoteResearch use only, not for human use.
-
Brief DescriptionLidocaine, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo, possibly due to an attenuation of pro-inflammatory cytokines.
-
DescriptionLidocaine, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo, possibly due to an attenuation of pro-inflammatory cytokines, intracellular adhesion molecule-1 (ICAM-1), and reduction of neutrophils influx.
-
SynonymsNSC 40030
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorH1 receptor
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number137-58-6
-
Formula Weight234.34
-
Molecular FormulaC14H22N2O
-
Purity>98%(HPLC)
-
SolubilityEthanol: 47 mg/mL (200.56 mM); Water: 9 mg/mL (38.4 mM); DMSO: 47 mg/mL (200.56 mM)
-
SMILESO=C(NC1=C(C)C=CC=C1C)CN(CC)CC
-
Chemical Name2',6'-Acetoxylidide, 2-(diethylamino)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sheets PL, et al. J Physiol. 2007 Jun 15;581(Pt 3):1019-3
molnova catalog
related products
-
Astemizole
Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
-
LML-134
LML-134 is an inverse agonist of Histamine 3 receptor (H3R)(hH3R cAMP and hH3R bdg with Kis of 0.3 nM and 12 nM).
-
Cetirizine dihydroch...
A second-generation antihistamine that acts as a selective H1 receptor antagonist.
